Castration-resistant prostate cancer (CRPC), a late-stage cancer which occurs when there is prostate-specific antigen (PSA) progression, despite consecutive standard hormonal manipulation, is typically a disease of elderly men and is associated with the development of osteoblastic bone metastases (9–11). This evidence concerns the gene KLK3 and cancer.